Clinical Trials Browser

Phase 1/2 × OTHER_GOV × Precursor Cell Lymphoblastic Leukemia-Lymphoma × Clear all

Graft vs Host Disease, Hodgkin Disease, Lymphoma, Non-Hodgkin, Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT05429905 2023-03-09

Dual Anti-CD22/CD19 Chimeric Antigen Receptor-directed T Cells (CART2219.1) for Relapsed Refractory B-Lineage Leukaemia

Phase 1/2 Unknown

48 enrolled

LymphoidOther hematologic neoplasm

Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT02772198 2020-11-03

T-cells Expressing Anti-CD19 CAR in Pediatric and Young Adults With B-cell Malignancies

Phase 1/2 Unknown

300 enrolled

LymphoidOther hematologic neoplasm

Lymphoma, Non-Hodgkin, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Clinical Trials

PTCy and ATG for MSD and MUD Transplants

Dual Anti-CD22/CD19 Chimeric Antigen Receptor-directed T Cells (CART2219.1) for Relapsed Refractory B-Lineage Leukaemia

T-cells Expressing Anti-CD19 CAR in Pediatric and Young Adults With B-cell Malignancies